The role of dance/movement therapy in the treatment of negative symptoms in schizophrenia: a mixed methods pilot study.
Karolina BrylJoke BradtAndrzej CechnickiKathleen FisherK Mark SossinSherry W GoodillPublished in: Journal of mental health (Abingdon, England) (2020)
Background: Optimizing psychosocial functioning by reducing the severity of negative symptoms are important outcomes for individuals with schizophrenia. Movement-based interventions could be uniquely capable of addressing the non-verbal nature of negative symptoms.Aims: To examine the treatment effects of a 10-week group dance/movement therapy program on negative symptoms and psychosocial functioning of individuals diagnosed with schizophrenia.Methods: A mixed methods intervention design (with explanatory intent) was used in which a randomized controlled trial was followed by semi-structured exit interviews. Participants diagnosed with schizophrenia (N = 31) were randomized to two conditions: treatment as usual (TAU) and dance/movement therapy (DMT). Before and after the program participants reported on negative symptoms and psychosocial functioning outcomes. Fifteen participants completed interviews.Results: Quantitative data showed no improvement nor worsening of clinical status in the DMT group. Qualitative data suggested that participation in DMT had a physical impact, resulted in enhanced interpersonal connectivity, sense of integration, emotional support, and symptom management.Conclusions: Qualitative but not quantitative findings suggest that DMT has potential to enhance psychosocial functioning and to reduce severity of negative symptoms for schizophrenia.
Keyphrases
- bipolar disorder
- mental health
- physical activity
- sleep quality
- randomized controlled trial
- systematic review
- high resolution
- stem cells
- risk assessment
- machine learning
- big data
- type diabetes
- bone marrow
- multiple sclerosis
- clinical trial
- metabolic syndrome
- double blind
- white matter
- mesenchymal stem cells
- phase iii
- resting state
- open label
- smoking cessation
- functional connectivity
- cerebrospinal fluid
- glycemic control